RNAZ (TransCode Therapeutics, Inc. Common Stock) Stock Analysis

TransCode Therapeutics, Inc. Common Stock (RNAZ) is a publicly traded Healthcare sector company. As of May 21, 2026, RNAZ trades at $6.35 with a market cap of $5.66M and a P/E ratio of -0.12. RNAZ moved +0.00% today. Year to date, RNAZ is -17.43%; over the trailing twelve months it is -25.12%. Its 52-week range spans $5.56 to $739.20. Rallies surfaces RNAZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest RNAZ stock research?

TransCode Therapeutics, Inc. Common Stock (RNAZ) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RNAZ moved +0.00% today.

RNAZ Key Metrics

Key financial metrics for RNAZ
MetricValue
Price$6.35
Market Cap$5.66M
P/E Ratio-0.12
EPS$-52.59
Dividend Yield0.00%
52-Week High$739.20
52-Week Low$5.56
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-34.66M
Gross Margin0.00%

Latest RNAZ News

Recent RNAZ Insider Trades

  • Fitzgerald Thomas A bought 49.35K (~$25.17K) on Sep 28, 2023.
  • Dudley Robert Michael bought 98.00K (~$49.98K) on Sep 28, 2023.
  • Dudley Robert Michael bought 12.00K (~$31.82K) on Jun 21, 2023.

RNAZ Analyst Consensus

RNAZ analyst coverage data. Average price target: $0.00.

Common questions about RNAZ

What can I research for RNAZ on Rallies?
TransCode Therapeutics, Inc. Common Stock (RNAZ) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RNAZ moved +0.00% today.
Does Rallies show live market data for RNAZ?
Rallies combines live market context with ticker research for RNAZ, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
RNAZ

RNAZ